FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3006404003> ?p ?o ?g. }

• W3006404003 endingPage "2972" @default.
• W3006404003 startingPage "2959" @default.
• W3006404003 abstract "// Nicole E. James 1 , 2 , Evelyn Cantillo 1 , Naohiro Yano 3 , Clinton O. Chichester 2 , Paul A. DiSilvestro 1 , 8 , Virginia Hovanesian 4 , R. Shyama Prasad Rao 5 , Kyukwang K. Kim 6 , Richard G. Moore 6 , Nagib Ahsan 7 , 8 and Jennifer R. Ribeiro 1 , 8 1 Division of Gynecologic Oncology, Program in Women&#x2019;s Oncology, Department of Obstetrics and Gynecology, Women and Infants Hospital, Providence, RI, USA 2 Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI, USA 3 Department of Surgery, Roger Williams Medical Center, Boston University Medical School, Providence, RI, USA 4 Core Research Laboratories, Rhode Island Hospital, Providence, RI, USA 5 Biostatistics and Bioinformatics Division, Yenepoya Research Center, Yenepoya University, Mangalore, India 6 Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA 7 Center for Cancer Research Development, Proteomics Core Facility, Rhode Island Hospital, Providence, RI, USA 8 Division of Biology and Medicine, Warren Alpert Medical School, Brown University, Providence, RI, USA Correspondence to: Nagib Ahsan, email: nagib_ahsan@brown.edu Jennifer R. Ribeiro, email: jrribeiro@wihri.org Keywords: ovarian cancer; proteomics; septin-2; metabolic proteins Received: December 18, 2018     Accepted: March 23, 2019     Published: April 26, 2019 ABSTRACT Epithelial Ovarian Cancer (EOC) is associated with dismal survival rates due to the fact that patients are frequently diagnosed at an advanced stage and eventually become resistant to traditional chemotherapeutics. Hence, there is a crucial need for new and innovative therapies. Septin-2, a member of the septin family of GTP binding proteins, has been characterized in EOC for the first time and represents a potential future target. Septin-2 was found to be overexpressed in serous and clear cell human patient tissue compared to benign disease. Stable septin-2 knockdown clones developed in an ovarian cancer cell line exhibited a significant decrease in proliferation rates. Comparative label-free proteomic analysis of septin-2 knockdown cells revealed differential protein expression of pathways associated with the TCA cycle, acetyl CoA, proteasome and spliceosome. Further validation of target proteins indicated that septin-2 plays a predominant role in post-transcriptional and translational modifications as well as cellular metabolism, and suggested the potential novel role of septin-2 in promoting EOC tumorigenesis through these mechanisms." @default.
• W3006404003 created "2020-02-24" @default.
• W3006404003 creator A5008347989 @default.
• W3006404003 creator A5011940400 @default.
• W3006404003 creator A5018377087 @default.
• W3006404003 creator A5021688199 @default.
• W3006404003 creator A5033923828 @default.
• W3006404003 creator A5036682715 @default.
• W3006404003 creator A5039881914 @default.
• W3006404003 creator A5052236281 @default.
• W3006404003 creator A5056675012 @default.
• W3006404003 creator A5056912647 @default.
• W3006404003 creator A5087118662 @default.
• W3006404003 date "2019-04-26" @default.
• W3006404003 modified "2023-10-05" @default.
• W3006404003 title "Septin-2 is overexpressed in epithelial ovarian cancer and mediates proliferation via regulation of cellular metabolic proteins" @default.
• W3006404003 cites W1200678608 @default.
• W3006404003 cites W1501060586 @default.
• W3006404003 cites W1843722816 @default.
• W3006404003 cites W1964895626 @default.
• W3006404003 cites W2001014988 @default.
• W3006404003 cites W2009051079 @default.
• W3006404003 cites W2009869135 @default.
• W3006404003 cites W2015246310 @default.
• W3006404003 cites W2017712517 @default.
• W3006404003 cites W2021108796 @default.
• W3006404003 cites W2025034353 @default.
• W3006404003 cites W2034400467 @default.
• W3006404003 cites W2037580878 @default.
• W3006404003 cites W2043333793 @default.
• W3006404003 cites W2046971177 @default.
• W3006404003 cites W2058783279 @default.
• W3006404003 cites W2062170156 @default.
• W3006404003 cites W2068176361 @default.
• W3006404003 cites W2083903970 @default.
• W3006404003 cites W2084121216 @default.
• W3006404003 cites W2091884933 @default.
• W3006404003 cites W2092713709 @default.
• W3006404003 cites W2096057003 @default.
• W3006404003 cites W2105145042 @default.
• W3006404003 cites W2112187659 @default.
• W3006404003 cites W2123792762 @default.
• W3006404003 cites W2125905177 @default.
• W3006404003 cites W2131401963 @default.
• W3006404003 cites W2136359150 @default.
• W3006404003 cites W2141955551 @default.
• W3006404003 cites W2148378558 @default.
• W3006404003 cites W2159250468 @default.
• W3006404003 cites W2163320603 @default.
• W3006404003 cites W2168070635 @default.
• W3006404003 cites W2267831227 @default.
• W3006404003 cites W2326824347 @default.
• W3006404003 cites W2326887391 @default.
• W3006404003 cites W2346986725 @default.
• W3006404003 cites W2464176087 @default.
• W3006404003 cites W2510028826 @default.
• W3006404003 cites W2513371636 @default.
• W3006404003 cites W2527233617 @default.
• W3006404003 cites W2552725973 @default.
• W3006404003 cites W2553794458 @default.
• W3006404003 cites W2555883279 @default.
• W3006404003 cites W2617314594 @default.
• W3006404003 cites W2617766232 @default.
• W3006404003 cites W2707568461 @default.
• W3006404003 cites W2738647095 @default.
• W3006404003 cites W2746650944 @default.
• W3006404003 cites W2767156664 @default.
• W3006404003 cites W2770489937 @default.
• W3006404003 cites W2802883877 @default.
• W3006404003 doi "https://doi.org/10.18632/oncotarget.26836" @default.
• W3006404003 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6508204" @default.
• W3006404003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31105878" @default.
• W3006404003 hasPublicationYear "2019" @default.
• W3006404003 type Work @default.
• W3006404003 sameAs 3006404003 @default.
• W3006404003 citedByCount "5" @default.
• W3006404003 countsByYear W30064040032020 @default.
• W3006404003 countsByYear W30064040032022 @default.
• W3006404003 countsByYear W30064040032023 @default.
• W3006404003 crossrefType "journal-article" @default.
• W3006404003 hasAuthorship W3006404003A5008347989 @default.
• W3006404003 hasAuthorship W3006404003A5011940400 @default.
• W3006404003 hasAuthorship W3006404003A5018377087 @default.
• W3006404003 hasAuthorship W3006404003A5021688199 @default.
• W3006404003 hasAuthorship W3006404003A5033923828 @default.
• W3006404003 hasAuthorship W3006404003A5036682715 @default.
• W3006404003 hasAuthorship W3006404003A5039881914 @default.
• W3006404003 hasAuthorship W3006404003A5052236281 @default.
• W3006404003 hasAuthorship W3006404003A5056675012 @default.
• W3006404003 hasAuthorship W3006404003A5056912647 @default.
• W3006404003 hasAuthorship W3006404003A5087118662 @default.
• W3006404003 hasBestOaLocation W30064040031 @default.
• W3006404003 hasConcept C10885799 @default.
• W3006404003 hasConcept C121608353 @default.
• W3006404003 hasConcept C126322002 @default.
• W3006404003 hasConcept C143998085 @default.
• W3006404003 hasConcept C161191863 @default.
• W3006404003 hasConcept C2776598537 @default.

• next